Prepared under contract for the National Cancer Institute. Supported, in part, by grant RO1-AG15340 from the National Institute on Aging. The views expressed in this article are those of the authors and do not reflect those of the National Cancer Institute or the Agency for Healthcare Research and Quality.
Mortality: What Are the Roles of Risk Factor Prevalence, Screening, and Use of Recommended Treatment?
Article first published online: 6 JUN 2006
The Journal of Rural Health
Volume 21, Issue 2, pages 149–157, March 2005
How to Cite
Yabroff, K. R., Lawrence, W. F., King, J. C., Mangan, P., Washington, K. S., Yi, B. and Mandelblatt, J. S. (2005), Mortality: What Are the Roles of Risk Factor Prevalence, Screening, and Use of Recommended Treatment?. The Journal of Rural Health, 21: 149–157. doi: 10.1111/j.1748-0361.2005.tb00075.x
- Issue published online: 6 JUN 2006
- Article first published online: 6 JUN 2006
ABSTRACT: Context: Despite advances in early detection and prevention of cervical cancer, women living in rural areas, and particularly in Appalachia, the rural South, the Texas/Mexico border, and the central valley of California, have had consistently higher rates of cervical cancer mortality than their counterparts in other areas during the past several decades. Methods: This paper reviews the published literature from 1966 to July 2002 to assess three potential pathways underlying this excess mortality—high human papilloma virus (HPV) prevalence, lack of or infrequent screening and advanced disease at diagnosis, and under-use of recommended treatment and shorter survival. Findings: Living in rural areas may impose barriers to cervical cancer control, including lack of transportation and medical care infrastructures. Population characteristics that place women at greater risk for developing and dying from cervical cancer, such as low income, lack of health insurance, and physician availability, are concentrated in rural areas. Published data, however, are insufficient to identify the key reasons for the observed mortality patterns. Conclusions: At this time, given the lack of definitive evidence in the published literature, decisions about priorities in areas with high rates of cervical cancer mortality will depend on knowledge of current levels of screening, incidence, and stage distribution; and service delivery infrastructures, resources, and acceptability of interventions to the target population.